Dienestrol

CAS No. 84-17-3

Dienestrol( Dienestrol | Dehydrostilbestrol | Dienoestrol | Sexadien | Restrol )

Catalog No. M16128 CAS No. 84-17-3

Dienestrol is a synthetic, non-steroidal estrogen. It is an estrogen receptor agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 70 In Stock
10MG 29 In Stock
25MG 44 In Stock
50MG 62 In Stock
100MG 86 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dienestrol
  • Note
    Research use only, not for human use.
  • Brief Description
    Dienestrol is a synthetic, non-steroidal estrogen. It is an estrogen receptor agonist.
  • Description
    Dienestrol is a synthetic, non-steroidal estrogen. It is an estrogen receptor agonist. Estrogens work partly by increasing a normal clear discharge from the vagina and making the vulva and urethra healthy.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Dienestrol | Dehydrostilbestrol | Dienoestrol | Sexadien | Restrol
  • Pathway
    Endocrinology/Hormones
  • Target
    Estrogen Receptor/ERR
  • Recptor
    ER
  • Research Area
    Endocrinology
  • Indication
    ——

Chemical Information

  • CAS Number
    84-17-3
  • Formula Weight
    266.34
  • Molecular Formula
    C18H18O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    C/C=C(/C(=C/C)/C1=CC=C(C=C1)O)\C2=CC=C(C=C2)O
  • Chemical Name
    4-[(2E,4E)-4-(4-hydroxyphenyl)hexa-2,4-dien-3-yl]phenol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Juriansz RL, et al. Y Res. 1988 Jan 1;48(1):14-8.
molnova catalog
related products
  • Palazestrant

    Palazestrant (OP-1250) is an orally available and highly potent estrogen receptor antagonist and selective ER degrader with antitumor activity.

  • Medicarpin (b)

    (+)-Medicarpin potently inhibits osteoclastogenesis and promotes bone healing and increases bone mass by osteoblast differentiation with estrogen receptor (ER) β-mediated osteogenic action.

  • OP-1074

    OP-1074 (OP1074) is a potent, selective ER degrader (SERD), shows specific antiestrogenic activity for both ERα and Erβ.